Poseida Therapeutics Announces Nomination of New CAR-T Development Candidate Under Collaboration with Roche October 22, 2024
Avacta and Tempus Enter Strategic Collaboration to Advance AI-Driven Drug Development in Oncology October 22, 2024
Nona Biosciences announced a strategic collaboration with OverT Bio to develop next-generation cell therapies for solid tumors October 15, 2024
Tempest Announces Agreement with Roche to Support Advancement of Amezalpat Combination Therapy into 1L HCC Pivotal Trial October 15, 2024
Exelixis and Merck to Evaluate Zanzalintinib in Combination With KEYTRUDA in Head and Neck Cancer and in Combination With WELIREG in RCC October 15, 2024
Ono Enters into License Agreement for LCB97 to generate novel ADC candidates by leveraging ConjuAll™ ADC platform with LigaChem Biosciences October 15, 2024
MediLink Announces Global Clinical Trial Collaboration and Supply Agreement on YL201 Combination Therapy October 15, 2024
MiNK Therapeutics and Autonomous Therapeutics Announce Collaboration to Develop Novel Therapies Targeting Metastatic Tumors October 15, 2024
Boehringer Ingelheim and Circle Pharma announce new research collaboration to develop a novel precision cancer treatment October 15, 2024
Cellipont Bioservices and Mongoose Bio to Advance TCR-T therapy MGB-001 for Multiple Cancers October 9, 2024
Aktis Oncology announces $175 million oversubscribed series B financing to further advance its proprietary radiopharmaceutical pipeline October 8, 2024
ABL Bio Announces Clinical Collaboration to Evaluate ABL103 in Combination with KEYTRUDA in Patients with Solid Tumors October 8, 2024
Galecto Completes Strategic Review to Focus on Oncology and Liver Disease and Acquires AML Preclinical Asset from Bridge Medicines October 8, 2024
Cartherics raises over $15 Million in oversubscribed private financing round to advance cell therapy programs October 8, 2024
Diakonos Oncology Announces Final Closing of Oversubscribed $11.4M Seed Financing to Advance DOC1021 into a Ph 2 Clinical Trial October 8, 2024
Enara Bio raises $32.5 million Series B financing to advance first-in-class pipeline of TCR-based immunotherapies targeting novel Dark Antigens® October 8, 2024
Merck Completes Acquisition of Investigational B-Cell Depletion Therapy, CN201, from Curon Biopharmaceutical October 8, 2024
Arcus Biosciences Announces Clinical Trial Collaboration Agreement to Evaluate Casdatifan in Combination with Volrustomig in RCC October 8, 2024
Regor Enters into a Definitive Purchase Agreement for Genentech to Acquire Regor’s Portfolio of next-gen CDK inhibitors for Treating Breast Cancer October 2, 2024
BioAtla and Context Therapeutics Announce Exclusive Worldwide License Agreement to Develop and Commercialize BA3362 October 2, 2024
LIfT BioSciences raises £10m in first close of Series A to advance first-in-class allogeneic innate cell therapy October 2, 2024
